Christy Shaffer knows more than a little something about running a company and raising venture capital.
She spent nearly 15 years as the president and CEO of Inspire Pharmaceuticals. During that time, she raised more than $300 million, took the company public and led its $430 million sale to Merck in 2010.
Today, she says she enjoys her seat on the other side of the funding table as a general partner at Hatteras Venture Partners in Durham.
Our Q&A:
- What is your investment focus?
I am a general partner at Hatteras Venture Partners and focus on the early-stage life science space. I work with strong academic groups, primarily on the east coast. We have invested in 9 companies from the University of North Carolina at Chapel Hill. However, our recent investments include technologies from Georgia Tech, Emory, Harvard and Yale.
- What attracted you to investing?
I am a receptor pharmacologist by training and spent years in the pharma/biotech industry, including as a private/public company CEO. I had known Hatteras for many years and I was attracted to assist in building early-stage companies with strong and elegant scientific underpinnings.
Read the full post at:
http://exitevent.com/article/christy-shaffer-ceo-to-vc-11172016
